Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Regenerative Medicine Market

Veterinary Regenerative Medicine Market Share

Report ID: GMI9919
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Veterinary Regenerative Medicine Market Share

The competitive landscape of the veterinary regenerative medicine industry is characterized by numerous established players striving to capitalize on the growing demand for advanced animal healthcare solutions. Key players are dominating the market with their diverse portfolio of regenerative therapies and strong distribution networks. Also, collaborations between academic institutions and industry players for R&D further intensify competition. Furthermore, emerging startups are also making significant strides, leveraging innovative technologies and strategic partnerships to gain traction in this evolving market landscape.

Veterinary Regenerative Medicine Market Companies

Few of the prominent players operating in the veterinary regenerative medicine industry include:

Animal Cell Therapies, Inc.
Ardent
Bioceltix
Boehringer Ingelheim International GmbH
CTSL (Cell Therapy Sciences)
Dechra
Enso Discoveries
Magellan Stem Cells
Medrego
Regeneus Ltd (Cambium Bio Ltd.)
StemcellX
VetStem, Inc.
Zoetis Inc.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Global veterinary regenerative medicine industry was valued at USD 265.5 million in 2023 and is anticipated to register 9.9% CAGR between 2024 and 2032, driven by rising incidence of chronic and degenerative conditions and the growing advancement in regenerative medicine

The orthopedic segment in the market is expected to reach USD 278.1 million by 2032 due to its high demand for treatments addressing musculoskeletal issues prevalent in companion and livestock animals.

Asia Pacific veterinary regenerative medicine market is expected to witness USD 10.4% CAGR through 2032 due to increasing pet ownership, rising awareness about advanced veterinary treatments, and growing animal healthcare expenditure.

Animal Cell Therapies, Inc., Ardent, Bioceltix, Boehringer Ingelheim International GmbH, CTSL (Cell Therapy Sciences), Dechra, Enso Discoveries, Magellan Stem Cells, Medrego and Regeneus Ltd (Cambium Bio Ltd.), among others.